NCT04953312 2026-03-12
CALPRO
Assistance Publique - Hôpitaux de Paris
Phase NA Withdrawn
Clinical Trials
13 trialsNCT05854966 2024-09-19
CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT04205786 2024-08-21
Vitamin B12 for Aromatase Inhibitors Associated Musculoskeletal Symptoms in Breast Cancer
Case Comprehensive Cancer Center
Phase NA Withdrawn
NCT05653531 2023-07-20
HEPATICI
Centre Hospitalier Universitaire, Amiens
Phase NA Withdrawn
NCT03987568 2022-12-21
Characterize Tumor Hypoxia by Magnetic Resonance Imaging
Wake Forest University Health Sciences
Phase NA Withdrawn
NCT04150692 2022-01-24
Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma
Washington University School of Medicine
Phase 2 Withdrawn
NCT03419247 2021-04-01
Molecular Profiling of Advanced Biliary Tract Cancers
University Health Network, Toronto
Phase NA Withdrawn
NCT01434550 2017-02-23
Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Withdrawn
NCT02705339 2016-05-17
Rociletinib Genomic Landscape in Non-small Cell Lung Cancer (NSCLC)
Washington University School of Medicine
Phase 2 Withdrawn
NCT01302002 2016-02-23
The Use of Metformin in Early Breast Cancer Patients Pre-Surgery
Instituto Nacional de Cancer, Brazil
Phase EARLY_PHASE1 Withdrawn
NCT02100618 2015-07-20
Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study
GlaxoSmithKline
Phase 3 Withdrawn
NCT00601991 2013-04-02
A Multi-Center Phase 2 Study of VEGF Trap as a Single Agent in Acute Myeloid Leukemia
Vanderbilt-Ingram Cancer Center
Phase 2 Withdrawn
NCT01209013 2012-05-08
Oedisse
Pinnacle Biologics Inc.
Phase 3 Withdrawn